FIGURE

Fig. 9

ID

ZDB-FIG-250821-27

Publication

Bentanachs et al., 2025 - Telmisartan Reverses Hepatic Steatosis via PCK1 Upregulation: A Novel PPAR-independent Mechanism in Experimental Models of MASLD

Other Figures

All Figure Page

Back to All Figure Page

Fig. 9

Telmisartan effects on PCK1 expression. (A) Relative liver mRNA levels of Pck1 and Ubr5 from CT, HFHF and Tel groups. (B, C) Relative liver protein levels of PCK1, p-GSK3β and SIRT1 from the corresponding experimental groups. On the upper part of the figures, representative western blot bands are shown. (D) Ubiquitinated PCK1 protein levels relative to total PCK1 protein levels in the livers from CT, HFHFr and Tel groups. (E) Hepatic glycogen content from CT, HFHFr and Tel groups. Quantitative results are presented as bar plots with individual values, showing the mean ± SD of 6–8 animals/group. *P < 0.05, **P < 0.01.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmacol. Res.